OBSTETRIC OUTCOMES OF PRE-ECLAMPSIA MANAGEMENT AT HANOI OBSTETRICS AND GYNECOLOGY HOSPITAL IN 2024
Main Article Content
Abstract
Objective: To evaluate obstetric outcomes in pregnant women with pre-eclampsia (PE) at Hanoi Obstetrics and Gynecology Hospital in 2024. Subjects and Methods: A retrospective cross-sectional descriptive study was conducted on 84 pregnant women diagnosed with PE at Hanoi Obstetrics and Gynecology Hospital from January 1, 2024, to December 31, 2024. Results: Among the 84 cases, 76.2% were diagnosed with severe PE, while 23.8% had non-severe PE. The majority of patients underwent cesarean section, accounting for 97.6%. ICU admission occurred in 9.5% of cases. The average gestational age at termination of pregnancy (TOP) was lower in the severe PE group compared to the non-severe group (32.2 ± 3 weeks vs. 35.7 ± 1.9 weeks). At 1 minute after birth, 40.6% of newborns in the severe PE group had an APGAR score < 7, compared to only 5% in the non-severe group. At 5 minutes, there was no significant difference between the groups, with most newborns scoring > 7. Newborns in the severe PE group had lower birth weights, both in average weight and in the proportion of low birth weight infants. Among adverse neonatal outcomes, the most common was birth weight < 2000g (52 cases), followed by postnatal respiratory support (48 cases). There was only one case of perinatal death and no cases of stillbirth. Conclusion: Cesarean section was the primary method of TOP in PE cases, accounting for 97.6%. Maternal complications included ICU transfer (9.5%), liver dysfunction (3.6%), HELLP syndrome (1.2%), and pulmonary edema (1.2%), with no maternal deaths. Low birth weight (< 2kg) occurred in 61.9% of newborns, respiratory support was required in 57.1%, and perinatal mortality was 1.2%, with no stillbirths. Pregnant women with severe PE tended to have worse obstetric outcomes for both mother and child.
Article Details
Keywords
Hypertensive disorders in pregnancy, pre-eclampsia, termination of pregnancy
References
2. C. V. Ananth, K. M. Keyes, R. J. Wapner. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. Nov 7 2013;347:f6564.
3. Y. Yang, I. Le Ray, J. Zhu, J. Zhang, J. Hua, M. Reilly. Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Netw Open. May 3 2021;4(5):e218401.
4. Đặng Công Việt. "Nghiên cứu chẩn đoán và xử trí tiền sản giật tại Bệnh viện Phụ Sản Trung ương". Luận văn thạc sĩ Y học, 2020.
5. Cao Thị Hảo. "Kết quả tiền sản giật trong 3 tháng cuối thai kỳ tại bệnh viện Sản nhi Nghệ An trong 2 năm 2021-2022". Luận văn thạc sĩ Y học, 2023;
6. Vũ Hồng Thăng. "Kết quả xử trí thai nghén sản phụ tiền sản giật tại Bệnh viện Phụ sản Trung Ương". Luận văn thạc sĩ Y học, 2022.
7. R. Munoz-Hernandez, P. Medrano-Campillo, M. L. Miranda, et al. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome. Am J Hypertens. Jul 1 2017;30(7):673-682.
8. C. H. Backes, K. Markham, P. Moorehead, L. Cordero, C. A. Nankervis, P. J. Giannone. Maternal preeclampsia and neonatal outcomes. J Pregnancy. 2011;2011:214365.